Systematisches Review zur Schätzung der Prävalenz entzündlich rheumatischer Erkrankungen in Deutschland

[1]  U. Marschall,et al.  Identification of rheumatoid arthritis in German claims data using different algorithms: Validation by cross‐sectional patient‐reported survey data , 2022, Pharmacoepidemiology and drug safety.

[2]  N. Mena-Vázquez,et al.  Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis , 2022, Journal of clinical medicine.

[3]  A. Strangfeld,et al.  Steigt die Prävalenz der rheumatoiden Arthritis wirklich an? , 2022, Zeitschrift für Rheumatologie.

[4]  H. Westerlind,et al.  Incidence and prevalence of systemic sclerosis in Sweden, 2004-2015, a register-based study. , 2022, Seminars in arthritis and rheumatism.

[5]  A. Semb,et al.  Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents , 2022, Scandinavian journal of rheumatology.

[6]  O. Hilberg,et al.  Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung Disease: A nationwide retrospective cohort study , 2022, Chronic respiratory disease.

[7]  Matthias Schneider,et al.  Risk of psoriatic arthritis depending on age: analysis of data from 65 million people on statutory insurance in Germany , 2021, RMD Open.

[8]  J. McDonagh,et al.  Incidence and prevalence of juvenile idiopathic arthritis in the United Kingdom, 2000–2018: results from the Clinical Practice Research Datalink , 2021, Rheumatology.

[9]  B. Heitmann,et al.  Age and Sex Specific Trends in Incidence of Juvenile Idiopathic Arthritis in Danish Birth Cohorts from 1992 to 2002: A Nationwide Register Linkage Study , 2021, International journal of environmental research and public health.

[10]  M. Augustin,et al.  Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis , 2021, Acta dermato-venereologica.

[11]  U. Marschall,et al.  Prescription of analgesics in patients with rheumatic diseases in Germany , 2021, Zeitschrift für Rheumatologie.

[12]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: An updated guideline for reporting systematic reviews , 2021, PLoS medicine.

[13]  A. Schwarting,et al.  The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization , 2021, Rheumatology and Therapy.

[14]  P. Rutherford,et al.  New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a claims data study. , 2021, Rheumatology.

[15]  R. Suruki,et al.  Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study , 2020, Advances in Therapy.

[16]  C. Kienitz,et al.  Prävalenz der Rheumatoiden Arthritis in Deutschland: Analyse von Längsschnittdaten der Gesetzlichen Krankenversicherung , 2020, Das Gesundheitswesen.

[17]  C. Turesson,et al.  Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review. , 2020, Seminars in arthritis and rheumatism.

[18]  M. Sticherling,et al.  Psoriatic arthritis epidemiology, comorbid disease profiles and risk factors: results from a claims database analysis , 2020, Rheumatology advances in practice.

[19]  H. Völzke,et al.  Häufigkeiten muskuloskelettaler Symptome und Erkrankungen in der bevölkerungsbezogenen NAKO Gesundheitsstudie , 2020, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[20]  L. G. García Rodríguez,et al.  Contemporary epidemiology of systemic sclerosis: A population-based cohort study in the United Kingdom. , 2019, Seminars in arthritis and rheumatism.

[21]  J. Braun,et al.  Versorgungssituation von Patienten mit ankylosierender Spondylitis und Psoriasisarthritis in Deutschland , 2019, Zeitschrift für Rheumatologie.

[22]  N. M. E. G. N. Marty, E. Gysling,et al.  Polymyalgia rheumatica , 2018, Aktuelle Rheumatologie.

[23]  Matthias Schneider,et al.  Prevalence and incidence of psoriasis and psoriatic arthritis , 2018, Annals of the rheumatic diseases.

[24]  S. Jugl,et al.  Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis , 2018, Rheumatology International.

[25]  G. Corrao,et al.  Prevalence and incidence of psoriatic arthritis: A systematic review and meta-analysis. , 2018, Seminars in arthritis and rheumatism.

[26]  W. Sondermann,et al.  Analysis of pharmaceutical care in patients with psoriatic arthritis using statutory health insurance data , 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[27]  W. Rüther,et al.  [Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Württemberg]. , 2018, Zeitschrift fur Rheumatologie.

[28]  Michael Doherty,et al.  The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies , 2017, Rheumatology.

[29]  K. Minden,et al.  Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis. , 2017, Seminars in arthritis and rheumatism.

[30]  I. Lundberg,et al.  Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study , 2017, Rheumatology.

[31]  A. Zink,et al.  Wie häufig sind muskuloskeletale Erkrankungen in Deutschland? , 2016, Zeitschrift für Rheumatologie.

[32]  F. Hoffmann,et al.  Prävalenz der rheumatoiden Arthritis in Deutschland auf Basis von Kassendaten , 2016, Zeitschrift für Rheumatologie.

[33]  M. Doherty,et al.  The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012 , 2014, Annals of the rheumatic diseases.

[34]  R. Zhong,et al.  Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis , 2014, Annals of the rheumatic diseases.

[35]  R. Fischer-Betz,et al.  Age-specific prevalence of diagnosed systemic lupus erythematosus in Germany 2002 and projection to 2030 , 2014, Lupus.

[36]  W. Gross,et al.  Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. , 2014, Rheumatology.

[37]  L. Kanz,et al.  High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study , 2014, Rheumatology International.

[38]  J. Reveille,et al.  The Epidemiology of Back Pain, Axial Spondyloarthritis and HLA-B27 in the United States , 2013, The American journal of the medical sciences.

[39]  F. Blyth,et al.  Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. , 2012, Journal of clinical epidemiology.

[40]  R. Schmidt,et al.  Epidemiologie des primären Sjögren-Syndroms , 2010, Zeitschrift für Rheumatologie.

[41]  K. Reich,et al.  Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[42]  K. Reich,et al.  Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque‐type psoriasis , 2009, The British journal of dermatology.

[43]  H. Lorenz,et al.  Prävalenz, Komorbidität und interdisziplinäre Versorgung der Rheumatoiden Arthritis – Versicherungsdaten zur ambulanten und stationären Versorgung in Baden-Württemberg , 2017, Zeitschrift für Rheumatologie.

[44]  J. Gottenberg,et al.  Incidence and prevalence of inflammatory myopathies: a systematic review. , 2015, Rheumatology.